ICON PLCICLREarnings & Financial Report
ICON plc is an Irish headquartered multinational healthcare intelligence and clinical research organisation. As of February 2025 had approximately 41,900 employees in 55 countries.
ICLR Q3 FY2025 Key Financial Metrics
Revenue
$2.0B
Gross Profit
N/A
Operating Profit
$86.6M
Net Profit
$2.4M
Gross Margin
N/A
Operating Margin
4.2%
Net Margin
0.1%
YoY Growth
0.6%
EPS
$0.03
ICON PLC Q3 FY2025 Financial Summary
ICON PLC reported revenue of $2.0B (up 0.6% YoY) for Q3 FY2025, with a net profit of $2.4M (down 98.8% YoY) (0.1% margin).
Key Financial Metrics
| Total Revenue | $2.0B |
|---|---|
| Net Profit | $2.4M |
| Gross Margin | N/A |
| Operating Margin | 4.2% |
| Report Period | Q3 FY2025 |
Revenue Breakdown
ICON PLC Q3 FY2025 revenue of $2.0B breaks down across 4 segments, led by Other Customers at $681.3M (33.4% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Other Customers | $681.3M | 33.4% |
| Clients1125 | $549.4M | 26.9% |
| Clients15 | $503.3M | 24.6% |
| Clients610 | $308.8M | 15.1% |
ICON PLC Revenue by Segment — Quarterly Trend
ICON PLC revenue by segment across the last 4 reported quarters, showing how each business line (such as Other Customers and Clients1125) has evolved quarter over quarter.
| Segment | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 |
|---|---|---|---|---|
| Other Customers | $681.3M | $693.6M | $721.6M | $752.3M |
| Clients1125 | $549.4M | $522.2M | $475.9M | $453.2M |
| Clients15 | $503.3M | $503.6M | $498.5M | $502.6M |
| Clients610 | $308.8M | $298.0M | $305.4M | $321.9M |
ICON PLC Quarterly Revenue & Net Profit History
ICON PLC results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q3 FY2025 | $2.0B | +0.6% | $2.4M | 0.1% |
| Q2 FY2025 | $2.0B | -4.8% | $183.0M | 9.1% |
| Q1 FY2025 | $2.0B | -4.3% | $154.2M | 7.7% |
| Q3 FY2024 | $2.0B | -1.2% | $197.1M | 9.7% |
| Q2 FY2024 | $2.1B | +4.9% | $146.9M | 6.9% |
| Q1 FY2024 | $2.1B | +5.7% | $187.4M | 9.0% |
| Q3 FY2023 | $2.1B | +5.8% | $163.7M | 8.0% |
| Q2 FY2023 | $2.0B | +4.4% | $115.6M | 5.7% |
Income Statement
| Q2 2023 | Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.02B | $2.06B | $2.09B | $2.12B | $2.03B | $2.00B | $2.02B | $2.04B |
| YoY Growth | 4.4% | 5.8% | 5.7% | 4.9% | -1.2% | -4.3% | -4.8% | 0.6% |
Balance Sheet
| Q2 2023 | Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $17.11B | $17.03B | $17.05B | $16.97B | $17.21B | $16.72B | $16.60B | $16.51B |
| Liabilities | $8.31B | $8.07B | $7.62B | $7.38B | $7.44B | $7.22B | $7.05B | $7.17B |
| Equity | $8.80B | $8.96B | $9.43B | $9.59B | $9.77B | $9.50B | $9.56B | $9.33B |
Cash Flow
| Q2 2023 | Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $203.9M | $341.5M | $327.1M | $218.6M | $402.7M | $268.2M | $146.2M | $387.6M |